MindWalk Holdings HYFT
NASDAQ HYFT
$1.31 -0.02 (-1.50%)
As of: Sep 4, 2026 · 12:47 PM EDT

MindWalk Holdings (HYFT) Receivables - Net (2020 - 2026)

MindWalk Holdings (HYFT) posted quarterly Receivables - Net of $1.8 million for Q2 2026, down 36.2% year-over-year from $2.9 million in Q2 2025, and up 35.97% quarter-over-quarter from $1.4 million in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Receivables - Net (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Receivables - Net for 7 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Receivables - Net fell 36.2% year-over-year to $1.8 million; the TTM figure through Apr 2026 stood at $1.8 million (down 36.2% YoY), while the FY2026 annual figure was $1.8 million, down 37.55% from the prior year.
  • Receivables - Net advanced to $1.8 million in Q2 2026 per HYFT's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.0 million in Q4 2024 and bottomed at $1.3 million in Q3 2025.
  • Historically, Receivables - Net has averaged $2.2 million across 5 years, with a median of $2.3 million in 2024.
  • Annual changes were most pronounced in 2022 — Receivables - Net soared 40.28% — and 2026, when it slumped 46.58%.
  • MindWalk Holdings' Receivables - Net stood at $2.4 million in 2022, then climbed by 9.79% to $2.7 million in 2023, then increased by 12.63% to $3.0 million in 2024, then retreated by 25.21% to $2.2 million in 2025, then retreated by 17.92% to $1.8 million in 2026.
  • Business Quant data shows HYFT's Receivables - Net at $1.8 million in Q2 2026, $1.4 million in Q1 2026, and $2.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 MindWalk Holdings 60.76 Mn 52.48 Mn 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 1.84 Mn
Jan 31, 2026 1.36 Mn
Oct 31, 2025 2.25 Mn
Jul 31, 2025 1.32 Mn
Apr 30, 2025 2.89 Mn
Jan 31, 2025 2.54 Mn
Oct 31, 2024 3.01 Mn
Jul 31, 2024 1.83 Mn
Apr 30, 2024 2.80 Mn
Jan 31, 2024 2.25 Mn
Oct 31, 2023 2.67 Mn
Jul 31, 2023 2.67 Mn
Apr 30, 2023 2.40 Mn
Jan 31, 2023 1.69 Mn
Oct 31, 2022 2.43 Mn
Jul 31, 2022 2.10 Mn
Apr 30, 2022 1.98 Mn
Jan 31, 2022 1.95 Mn
Oct 31, 2021 1.73 Mn
Jul 31, 2021 2.24 Mn